amr industry alliance
The AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces.
read moreDOWNLOAD 2020 PROGRESS REPORT
We drive and measure the life-sciences industry progress to curb antimicrobial resistance in four different areas:
shared goals
We are uniting efforts to reduce the development of antimicrobial resistance, invest in R&D to meet public health needs and improve access to antibiotics, vaccines and diagnostics.
progress report
In 2020, the Alliance published its second progress report that provides unique insights into the practical steps its members are taking to respond to AMR. The findings of the report illustrate both the challenges the healthcare sector faces in tackling AMR and how the industry is essential to winning this battle.
in action
Our case studies provide snap-shots from across the life-sciences industry, share information on the tangible steps we are taking to invest in new research to develop new antibiotics and vaccines, prevent infection ,and improve appropriate use of antibiotics.
latest news
Request for Proposals: Regulatory Landscape Phase 1
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrobial resist...
Read more
Request for Proposals: Regulatory Landscape Phase 2
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrob...
Read more
Stewardship Prize: Strengthening Stewardship and Appropriate Use in Low- and Middle-Income Countries
About the Stewardship Prize While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, li...
Read moreamr in numbers
AMR Impact
Life-sciences at the forefront of the battle against AMR
Development of National Action Plans
R&D
Biotechs
Diagnostics
from the blog
Antimicrobial Resistance and the Burden of Sepsis
Sepsis is a devastating condition resulting from a dysregulated immune system response to infection, which can lead to organ failure and death. Each year, sepsis affects close to 50 million people globally, of whom more than 40% are children under age 5 particularly in low- and middle-income countri...
Read more view all
